Allena Pharmaceuticals
ALNA
ALNA was delisted on the 7th of September, 2022.
28 hedge funds and large institutions have $1.86M invested in Allena Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% less funds holding
Funds holding: 30 → 28 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
82% less capital invested
Capital invested by funds: $10.1M → $1.86M (-$8.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18K |
| 2 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$4.83K |
| 3 |
RA
RFG Advisory
Birmingham,
Alabama
|
+$4.55K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.41K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.37M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$581K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$472K |
| 4 |
Morgan Stanley
New York
|
-$428K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$294K |
ALNA Hedge Fund Activity: Q1 2022 in Review
28 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q1 2022, worth a combined $1.86M — down 82% from $10.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ALNA and 4 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, adding an estimated $18K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.37M sold.
- 28 institutional investors held Allena Pharmaceuticals (ALNA) as of Q1 2022, down from 30 in Q4 2021.
- Funds reported $1.86M of Allena Pharmaceuticals stock for Q1 2022, down 82% quarter-over-quarter.
- 4 funds opened new Allena Pharmaceuticals positions in Q1 2022 and 6 closed out, a net change of -2 holders.
- The largest Allena Pharmaceuticals buyer in Q1 2022 was Susquehanna International Group, an estimated $18K added.
- The largest Allena Pharmaceuticals seller in Q1 2022 was AIGH Capital Management, an estimated $2.37M sold.
Based on aggregated 13F filings for Q1 2022.